Suppr超能文献

实施与评估一项复杂干预措施,以提高患有多种疾病和多种药物治疗的老年患者住院与门诊护理衔接处的信息可得性(HYPERION-TransCare)——德国全科医疗中一项试点及可行性整群随机对照试验的研究方案

Implementation and evaluation of a complex intervention to improve information availability at the interface between inpatient and outpatient care in older patients with multimorbidity and polypharmacy (HYPERION-TransCare) - study protocol for a pilot and feasibility cluster-randomized controlled trial in general practice in Germany.

作者信息

Klein Astrid-Alexandra, Petermann Jenny, Brosse Franziska, Piller Steve, Kramer Martin, Hanf Maria, Dinh Truc Sophia, Schulz-Rothe Sylvia, Engler Jennifer, Mergenthal Karola, Seidling Hanna M, Klasing Sophia, Timmesfeld Nina, van den Akker Marjan, Voigt Karen

机构信息

Department of General Practice/Medical Clinic III, Dresden Medical School, Dresden University of Technology, Dresden, Germany.

Institute of General Practice, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt Am Main, Germany.

出版信息

Pilot Feasibility Stud. 2023 Aug 22;9(1):146. doi: 10.1186/s40814-023-01375-2.

Abstract

BACKGROUND

Despite attempts to improve the cross-sectoral flow of information, difficulties remain in routine healthcare. The resulting negative impact on continuity of care is often associated with poor health outcomes, especially in older patients. Our intervention aims to increase information availability with respect to medications and health conditions at the interface between inpatient and outpatient care and to contribute towards improving the quality of care in older patients. This pilot study focuses on feasibility and implementability.

METHODS

The idea of the complex intervention has been developed in a previous study. This intervention will be tested in a prospective, multicenter, cluster-randomized (via web tool), controlled pilot trial with two parallel study arms (intervention and control group). The pilot study will be conducted in 20 general practices in Hesse and Saxony (Germany) and include 200 patients (≥ 65 years of age with multimorbidity and polypharmacy) recruited by the practices. Practice staff and patients will be blinded. We will use qualitative and quantitative methods to assess the feasibility and implementability of the intervention and the study design in a process evaluation covering topics ranging from expectations to experiences. In addition, the feasibility of proposed outcome parameters for the future definitive trial will be explored. The composite endpoint will include health-related patient outcomes (hospitalization, falls, and mortality using, e.g., the FIMA questionnaire), and we will assess information on medications (SIMS questionnaire), symptoms and side effects of the medication (pro-CTCAE questionnaire), and health literacy (HLQ questionnaire). Data will be collected at study begin (baseline) and after 6 months. Furthermore, the study will include surveys and interviews with patients, general practitioners, and healthcare assistants.

DISCUSSION

The intervention was developed using a participatory approach involving stakeholders and patients. It aims to empower general practice teams as they provide patient-centered care and play a key role in the coordination and continuity of care. We aim to encourage patients to adopt an active role in their health care. Overall, we want to increase the availability of health-related information for patients and healthcare providers. The results of the pilot study will be used in the design and implementation of the future definitive trial.

TRIAL REGISTRATION

The study was registered in DRKS-German Clinical Trials Register: registration number DRKS00027649 (date: 19 January 2022). Date and version identifier 10.07.2023; Version 1.3.

摘要

背景

尽管人们试图改善跨部门信息流通,但常规医疗保健中仍存在困难。由此对医疗连续性产生的负面影响往往与不良健康结果相关,尤其是在老年患者中。我们的干预措施旨在提高住院和门诊护理衔接处关于药物和健康状况的信息可用性,并有助于提高老年患者的护理质量。这项试点研究侧重于可行性和可实施性。

方法

在之前的一项研究中已提出了这种复杂干预措施的构想。该干预措施将在一项前瞻性、多中心、整群随机(通过网络工具)、有对照的试点试验中进行测试,试验设有两个平行研究组(干预组和对照组)。试点研究将在德国黑森州和萨克森州的20家普通诊所开展,纳入由这些诊所招募的200名患者(年龄≥65岁,患有多种疾病且使用多种药物)。诊所工作人员和患者将处于盲态。我们将使用定性和定量方法,在一个涵盖从期望到体验等主题的过程评估中,评估干预措施及研究设计的可行性和可实施性。此外,还将探索为未来确定性试验提议的结局参数的可行性。复合终点将包括与健康相关的患者结局(例如使用FIMA问卷评估住院、跌倒和死亡率),我们还将评估关于药物的信息(使用SIMS问卷)、药物的症状和副作用(使用pro-CTCAE问卷)以及健康素养(使用HLQ问卷)。数据将在研究开始时(基线)和6个月后收集。此外,该研究还将包括对患者、全科医生和医疗助理的调查和访谈。

讨论

该干预措施是采用一种让利益相关者和患者参与的方法制定的。其目的是增强全科医疗团队的能力,因为他们提供以患者为中心的护理,并在护理的协调和连续性方面发挥关键作用。我们旨在鼓励患者在自身医疗保健中发挥积极作用。总体而言,我们希望增加患者和医疗服务提供者可获取的与健康相关的信息。试点研究的结果将用于未来确定性试验的设计和实施。

试验注册

该研究已在德国临床试验注册中心(DRKS)注册:注册号DRKS00027649(日期:2022年1月19日)。日期和版本标识符10.07.2023;版本1.3

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee36/10463488/8d52176c2493/40814_2023_1375_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验